Bazedoxifene (Wyeth)
- PMID: 15535430
Bazedoxifene (Wyeth)
Abstract
Bazedoxifene is a tissue-specific selective estrogen receptor modulator being developed by Wyeth Pharmaceuticals (formerly Wyeth-Ayerst Laboratories) to be used alone for the prevention and treatment of osteoporosis in postmenopausal women and in combination with Premarin for menopausal symptoms. As of March and June 2004, worldwide phase III trials for bazedoxifene, and bazedoxifene in combination with Premarin, were ongoing.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials